(NASDAQ: QTTB) Q32 Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.
Q32 Bio's earnings in 2025 is -$52,304,000.On average, 2 Wall Street analysts forecast QTTB's earnings for 2025 to be -$49,278,365, with the lowest QTTB earnings forecast at -$50,498,126, and the highest QTTB earnings forecast at -$48,058,603. On average, 2 Wall Street analysts forecast QTTB's earnings for 2026 to be -$45,619,080, with the lowest QTTB earnings forecast at -$62,451,789, and the highest QTTB earnings forecast at -$28,786,371.
In 2027, QTTB is forecast to generate -$54,584,327 in earnings, with the lowest earnings forecast at -$69,160,477 and the highest earnings forecast at -$40,008,177.